ArticleThe journal of pathology. Clinical research2019

Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study).

Kate Packwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.